Patents Assigned to Wesleyan University
-
Patent number: 11764832Abstract: Systems, methods, and media for wireless power transfer are provided.Type: GrantFiled: December 14, 2021Date of Patent: September 19, 2023Assignees: UNIVERSITY OF MARYLAND, COLLEGE PARK, WESLEYAN UNIVERSITYInventors: Lei Chen, Steven Mark Anlage, Tsampikos Kottos
-
Patent number: 8551700Abstract: The invention provides methods for diagnosing biological states or conditions based on ratios of gene expression data from tissue samples, such as cancer tissue samples. The invention also provides sets of genes that are expressed differentially in malignant pleural mesothelioma. These sets of genes can be used to discriminate between normal and malignant tissues, and between classes of malignant tissues. Accordingly, diagnostic assays for classification of tumors, prediction of tumor outcome, selecting and monitoring treatment regimens and monitoring tumor progression/regression also are provided.Type: GrantFiled: July 12, 2010Date of Patent: October 8, 2013Assignees: The Brigham and Women's Hospital, Inc., Wesleyan UniversityInventors: Gavin J. Gordon, Roderick V. Jensen, Steven R. Gullans, Li-Li Hsiao, Raphael Bueno
-
Publication number: 20120123059Abstract: Disclosed herein are copolymers comprising functional groups attached to the backbone of the polymer and methods of making these polymers.Type: ApplicationFiled: December 19, 2008Publication date: May 17, 2012Applicant: WESLEYAN UNIVERSITYInventor: Joseph W. Bruno
-
Publication number: 20110059854Abstract: The invention provides methods for diagnosing biological states or conditions based on ratios of gene expression data from tissue samples, such as cancer tissue samples. The invention also provides sets of genes that are expressed differentially in malignant pleural mesothelioma. These sets of genes can be used to discriminate between normal and malignant tissues, and between classes of malignant tissues. Accordingly, diagnostic assays for classification of tumors, prediction of tumor outcome, selecting and monitoring treatment regimens and monitoring tumor progression/regression also are provided.Type: ApplicationFiled: July 12, 2010Publication date: March 10, 2011Applicants: THE BRIGHAM AND WOMEN'S HOSPITAL, INC., WESLEYAN UNIVERSITYInventors: GAVIN J. GORDON, RODERICK V. JENSEN, STEVEN R. GULLANS, LI-LI HSIAO, RAPHAEL BUENO
-
Publication number: 20100134631Abstract: A real-time image compression method includes identifying pixels in a set of image data that have a brightness value past a predetermined threshold; determining a position of each identified pixel in the image data; and for each of the identified pixels, defining a vector that includes the brightness value and the position of the identified pixel in the image data.Type: ApplicationFiled: October 25, 2007Publication date: June 3, 2010Applicant: WESLEYAN UNIVERSITYInventors: Greg Voth, Dominick Stich, King-Yeung Chan
-
Patent number: 7622260Abstract: The invention provides methods for diagnosing biological states or conditions based on ratios of gene expression data from tissue samples, such as cancer tissue samples. The invention also provides sets of genes that are expressed differentially in malignant pleural mesothelioma. These sets of genes can be used to discriminate between normal and malignant tissues, and between classes of malignant tissues. Accordingly, diagnostic assays for classification of tumors, prediction of tumor outcome, selecting and monitoring treatment regimens and monitoring tumor progression/regression also are provided.Type: GrantFiled: September 5, 2002Date of Patent: November 24, 2009Assignees: The Brigham and Women's Hospital, Inc., Wesleyan UniversityInventors: Gavin J. Gordon, Roderick V. Jensen, Steven R. Gullans, Raphael Bueno, Li-Li Hsiao
-
Publication number: 20090104617Abstract: The invention provides methods for diagnosing biological states or conditions based on ratios of gene expression data from tissue samples, such as cancer tissue samples. The invention also provides sets of genes that are expressed differentially in malignant pleural mesothelioma. These sets of genes can be used to discriminate between normal and malignant tissues, and between classes of malignant tissues. Accordingly, diagnostic assays for classification of tumors, prediction of tumor outcome, selecting and monitoring treatment regimens and monitoring tumor progression/regression also are provided.Type: ApplicationFiled: December 5, 2008Publication date: April 23, 2009Applicants: The Brigham And Women's Hospital, Inc., Wesleyan UniversityInventors: Gavin J. Gordon, Roderick V. Jensen, Steven R. Gullans, Li-Li Hsiao, Raphael Bueno
-
Patent number: 5155546Abstract: A method for quantitatively determining the total organic carbon and vitrinite reflectance of rocks and sediments utilizes the entire visible light spectrum. A sample is prepared and placed in a spectrophotometer. The spectrophotometer has a light source that produces the entire visible light spectrum. A monochromator passes narrow wavelength bands of the source light therethrough to illuminate the sample. The total diffuse reflectance spectrum is obtained from the sample using the spectrophotometer. The reflectance spectral data are processed by determining the first derivative and by comparing it to calibration data of known total organic carbon and vitrinite reflectance.Type: GrantFiled: June 3, 1991Date of Patent: October 13, 1992Assignee: Texas Wesleyan University, Inc.Inventors: William L. Balsam, Bobby C. Deaton